Login / Signup
Fedi Zouari
Publication Activity (10 Years)
Years Active: 2022-2023
Publications (10 Years): 7
Top Topics
Liver Disease
Top Venues
EMBC
</>
Publications
</>
Pak To Cheung
,
Fedi Zouari
,
Adrien Touboul
,
Cheuk Man Ho
,
Venice Sin
,
Eddie C. Wong
,
Iris Yuwen Zhou
,
Desmond Y. H. Yap
,
Russell W. Chan
Electric impedance tomography enables portable and non-invasive approach to screen and monitor chronic kidney disease.
EMBC
(2023)
Shihao Zeng
,
Wang Chun Kwok
,
Peng Cao
,
Fedi Zouari
,
Philip Tin Yun Lee
,
Russell W. Chan
,
Adrien Touboul
Deep learning based reconstruction enables high-resolution electrical impedance tomography for lung function assessment.
EMBC
(2023)
James H. W. Li
,
Adrien Touboul
,
Fedi Zouari
,
Pak To Cheung
,
Ellie Wei
,
Eddie C. Wong
,
Iris Yuwen Zhou
,
Man-Fung Yuen
,
Wai-Kay Seto
,
Lung-Yi Mak
,
Russell W. Chan
Portable electrical impedance tomography (EIT) system stages non-alcoholic fatty liver disease for potential screening and monitoring at home.
EMBC
(2023)
Fedi Zouari
,
Pak To Cheung
,
Adrien Touboul
,
Wang Chun Kwok
,
Venice Sin
,
Eddie C. Wong
,
Iris Y. Zhou
,
Terence Chi Chun Tam
,
Russell W. Chan
Global and regional lung function assessment using portable electrical impedance tomography (EIT) system: clinical study.
EMBC
(2023)
Omer Raza
,
Michael Lawson
,
Fedi Zouari
,
Eddie C. Wong
,
Russell W. Chan
,
Peng Cao
CycleGAN with mutual information loss constraint generates structurally aligned CT images from functional EIT images.
EMBC
(2023)
Fedi Zouari
,
Wei Yi Oon
,
Dipyaman Modak
,
Wang Chun Kwok
,
Peng Cao
,
Wei-Ning Lee
,
Terence Chi Chun Tam
,
Eddie C. Wong
,
Russell W. Chan
Standalone electrical impedance tomography predicts spirometry indicators and enables regional lung assessment.
EMBC
(2022)
Adrien Touboul
,
Fedi Zouari
,
Luca Minciullo
,
Dipyaman Modak
,
Raymond M. V. Lee
,
Eddie C. Wong
,
Man-Fung Yuen
,
Wai-Kay Seto
,
Lung-Yi Mak
,
Russell W. Chan
Unmixing multi-spectral electrical impedance tomography (EIT) predicts clinical-standard controlled attenuation parameter (CAP) for nonalcoholic fatty liver disease classification: a feasibility study.
EMBC
(2022)